Sign in
Taking people in United StatesNo phase

Portable chest X-ray screening for tuberculosis in migrant communities in New York City

Tests portable chest X-ray screening for tuberculosis in migrant adults in New York City.

Key facts

Who runs it
Columbia University
Where
New York, United StatesSee the site
Trial code
Registry title
Screening With Portable X-rays for Rapid Recognition of TB
Status
Recruiting
People taking part
1,000 people, planned
Started
25 Aug 2026
Expected to end
25 May 2028
Type of study
Interventional
Treatments tested
  • Mobile chest radiography for tuberculosis screening
Record updated
2 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult migrants in New York City who arrived in the US within the last 24 months. It tests a community screening for tuberculosis (TB) using a portable chest X-ray.

Age
18 years or older
Sex
All sexes can join

Main reasons for not taking part

  • Cannot give informed consent
  • Cannot take part because study materials are not available in their language
  • Unwilling to participate
  • Prisoner
  • Pregnancy

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adult persons 18 years or older
  • Self-identifying as migrants to the US
  • Self-reporting migration within the 24 months

Who cannot take part

  • Lack capacity for informed consent
  • Unable to perform translation/study materials not available in appropriate language
  • Unwilling to participate
  • Prisoner
  • Pregnancy

Where in United States

  • African Services CommitteeNew York, United StatesContact: Allison Wolf, MPHTaking people

About the trial

What the trial wants to find out

SPOT-TB (Screening with Portable X-rays for rapid recOgniTion of TB) is a prospective study evaluating a community-based tuberculosis (TB) screening strategy for migrant populations in New York City. The screening intervention integrates mobile ultra-portable digital chest radiography with artificial intelligence-assisted image interpretation, tuberculosis symptom assessment, latent tuberculosis infection testing, and HIV testing. Participants with concerning screening findings are referred for appropriate clinical evaluation. The study will evaluate the feasibility, acceptability, and effectiveness of this integrated screening strategy for improving early identification of active pulmonary tuberculosis and linkage to care in community settings.

The group in the trial

  • SPOT-TB Screening InterventionTreatment being tested

    Participants undergo the SPOT-TB screening strategy, which includes symptom screening, chest radiography interpreted using AI software, HIV testing, and collection of sputum for confirmatory microbiologic testing when indicated.

    Treatment: Mobile chest radiography for tuberculosis screening

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Mobilizing Innovative Strategies to Improve Tuberculosis (TB) Diagnosis and Retention in the TB Care Cascade for Migrant Communities in New York City
Plain-language title
Portable chest X-ray screening for tuberculosis in migrant communities in New York CityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
2 October 2026